Atrial Fibrillation Latest News Archive

Oxygen Desaturation Index Predicts AFib Risk in Ischemic Stroke

Oxygen Desaturation Index Predicts AFib Risk in Ischemic Stroke

Investigators observed a significant association between atrial fibrillation and increasing oxygen desaturation index.

Variations in Published Stroke Rates Confound Net Anticoagulation Benefit Analyses

Variations in Published Stroke Rates Confound Net Anticoagulation Benefit Analyses

Variations in published stroke rates for patients with AF not receiving anticoagulants result in differences in the calculated net clinical benefit of anticoagulation.

New Apple Watch Includes Irregular Heart Rhythm Notification Feature

New Apple Watch Includes Irregular Heart Rhythm Notification Feature

The irregular rhythm notification feature analyzes pulse rate data to identify episodes of irregular heart rhythms.

VKA vs Non-VKA Oral Anticoagulants: Mortality Rates Compared in AF

VKA vs Non-VKA Oral Anticoagulants: Mortality Rates Compared in AF

The new analysis included 19,134 of these patients and showed that there were 19% fewer deaths in patients initiated on NOACs compared to VKAs at the time of AF diagnosis.

CHEST Releases Guideline for Antithrombotic Therapy in Atrial Fibrillation

CHEST Releases Guideline for Antithrombotic Therapy in Atrial Fibrillation

Patients with atrial fibrillation who have ≥1 non-sex CHA2DS2VASc stroke risk factor should receive oral anticoagulation as antithrombotic therapy.

CHA2DS2-VASc Scores Drive Clinical Outcomes in Atrial Fibrillation, Flutter

CHA2DS2-VASc Scores Drive Clinical Outcomes in Atrial Fibrillation, Flutter

Clinical outcomes in atrial fibrillation vs atrial flutter differ in terms of ischemic stroke, heart failure hospitalizations, and all-cause mortality.

Concomitant NSAID and Anticoagulant Use May Increase Stroke, Bleeding Risk in Afib

Concomitant NSAID and Anticoagulant Use May Increase Stroke, Bleeding Risk in Afib

Patients with atrial fibrillation who take NSAIDs in addition to oral anticoagulants may have an increased risk for major bleeding and stroke.

Hypothyroidism Predicts Atrial Tachyarrhythmia After AF Catheter Ablation

Hypothyroidism Predicts Atrial Tachyarrhythmia After AF Catheter Ablation

Patients with higher levels of thyroid-stimulating hormone were more likely to experience atrial tachyarrhythmia after catheter ablation for atrial fibrillation.

Atrial Fibrillation Development Predicted by Sleep Disruption

Atrial Fibrillation Development Predicted by Sleep Disruption

Individuals with more frequent nighttime awakening exhibited a higher risk for atrial fibrillation.

Asthma and Poorly Controlled Asthma May Increase Atrial Fibrillation Risk

Asthma and Poorly Controlled Asthma May Increase Atrial Fibrillation Risk

Individuals with clinician-diagnosed asthma were at an estimated 38% higher risk for atrial fibrillation.

Apixaban Lowers Bleeding Risk in Afib With End-Stage Kidney Disease

Apixaban Lowers Bleeding Risk in Afib With End-Stage Kidney Disease

Apixaban demonstrated superiority over warfarin in terms of reducing the risk for major bleeding in patients with atrial fibrillation and end-stage kidney disease who were on dialysis.

High-Risk Atrial Fibrillation Diagnosis Facilitated by Home-Based ECG

High-Risk Atrial Fibrillation Diagnosis Facilitated by Home-Based ECG

Using a continuous ECG monitoring patch at home in patients at high risk for atrial fibrillation resulted in higher diagnosis rates, more anticoagulation initiation, and increased healthcare resource utilization.

Troponin-T, NT-proBNP May Predict Mortality Risk in Atrial Fibrillation

Troponin-T, NT-proBNP May Predict Mortality Risk in Atrial Fibrillation

Troponin-T, N-terminal pro-B-type natriuretic peptide, and growth differentiation factor-15 may offer prognostic utility on mortality and bleeding events in patients with atrial fibrillation who receive anticoagulation.

Rivaroxaban Use in Older Patients: Does Age Influence Safety, Efficacy?

Rivaroxaban Use in Older Patients: Does Age Influence Safety, Efficacy?

Data from large Phase 3 studies showed that treatment with rivaroxaban was found to be safe and effective in older patients.

New Coagulation Monitoring Device Allows for Wireless Reporting of INR Results

New Coagulation Monitoring Device Allows for Wireless Reporting of INR Results

The system is intended for properly selected trained users ≥22 years of age who have been stabilized on anticoagulation with vitamin K antagonists for ≥6 weeks.

Stroke Risk Highest in Paroxysmal Afib With Greater Burden of Afib

Stroke Risk Highest in Paroxysmal Afib With Greater Burden of Afib

A greater burden of atrial fibrillation or flutter in patients with paroxysmal atrial fibrillation was associated with a higher risk for stroke when not taking anticoagulants.

COPD May Increase the Risk for Atrial Fibrillation

COPD May Increase the Risk for Atrial Fibrillation

Patients with COPD had a nearly 2-fold increased risk for developing atrial fibrillation compared with patients without COPD.

Andexxa Approved for Reversing Anticoagulant Activity of Rivaroxaban, Apixaban

Andexxa Approved for Reversing Anticoagulant Activity of Rivaroxaban, Apixaban

Andexxa, a recombinant modified human Factor Xa (FXa) protein, was approved under the FDA's Accelerated Approval pathway.

Afib Risk Not Affected by Borderline ABI in Peripheral Artery Disease

Afib Risk Not Affected by Borderline ABI in Peripheral Artery Disease

Peripheral artery disease with a borderline ankle-branchial index appears not to increase the risk for atrial fibrillation.

Anxiety May Increase Stroke, Intracranial Hemorrhage in Atrial Fibrillation

Anxiety May Increase Stroke, Intracranial Hemorrhage in Atrial Fibrillation

Anxiety may increase the risk for ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation.

Praxbind Gains Full FDA Approval as Pradaxa Reversal Agent

Praxbind Gains Full FDA Approval as Pradaxa Reversal Agent

Complete reversal was seen within 4 hours in the majority of patients, as measured by ecarin clotting time (ECT 82%) or diluted thrombin time (dTT 99%). In addition, there was a low late of thrombotic events and no new safety events were reported.

Pulmonary Arterial Hypertension Outcomes With Atrial Arrhythmia

Pulmonary Arterial Hypertension Outcomes With Atrial Arrhythmia

Increased right atrial and pulmonary wedge pressures and increased thyroid disease prevalence were associated with atrial arrhythmia development in idiopathic or systemic sclerosis-related pulmonary arterial hypertension.

Influenza Vaccination May Reduce Mortality Risk in Heart Failure

Influenza Vaccination May Reduce Mortality Risk in Heart Failure

A meta-analysis sought to determine the effect of influenza vaccination on cardiac-related mortality in patients with heart failure.

Targeting Underlying Conditions May Improve Sinus Rhythm in Atrial Fibrillation

Targeting Underlying Conditions May Improve Sinus Rhythm in Atrial Fibrillation

Patients with persistent atrial fibrillation who received targeted therapy saw improvements in sinus rhythm as well as reductions in blood pressure, cholesterol, and weight.

Atrial Fibrillation Treated With LAA Occlusion Reduces Thromboembolism Risk

Atrial Fibrillation Treated With LAA Occlusion Reduces Thromboembolism Risk

Surgical left atrial appendage occlusion is associated with a lower risk for thromboembolism-related hospital readmission in older patients with atrial fibrillation who undergo cardiac surgery.

Ischemic Stroke Risk in Atrial Flutter vs Fibrillation

Ischemic Stroke Risk in Atrial Flutter vs Fibrillation

Patients with atrial fibrillation have a higher risk for ischemic stroke compared with patients with atrial flutter.

Measuring Cost-Effectiveness of DOACs, Warfarin for Stroke Prevention

Measuring Cost-Effectiveness of DOACs, Warfarin for Stroke Prevention

Cost-effective DOACs like apixaban prevent strokes better than warfarin in patients with atrial fibrillation.

Bleeding Risk, Stroke Outcomes With Edoxaban vs Enoxaparin-Warfarin for Cardioversion of Atrial Fibrillation

Bleeding Risk, Stroke Outcomes With Edoxaban vs Enoxaparin-Warfarin for Cardioversion of Atrial Fibrillation

In patients with atrial fibrillation at high risk for stroke, edoxaban is associated with lower rates of cardiovascular death events.

Short-Run Atrial Tachyarrhythmia Associated With Increased Stroke Risk

Short-Run Atrial Tachyarrhythmia Associated With Increased Stroke Risk

Patients who had short-run atrial tachyarrhythmia experienced significantly higher rates of stroke compared with patients who did not have short-run atrial tachyarrhythmia.

Renal Function Outcomes in Atrial Fibrillation With Oral Anticoagulation Therapy

Renal Function Outcomes in Atrial Fibrillation With Oral Anticoagulation Therapy

Patients with atrial fibrillation who are treated with oral anticoagulants often experience renal function decline.

Leukocyte Telomere Length as Potential Biomarker for Atrial Fibrillation

Leukocyte Telomere Length as Potential Biomarker for Atrial Fibrillation

No significant association was found between atrial fibrillation risk and leukocyte telomere length.

Atrial Fibrillation Detected on Apple Watch Heart Rhythm Device

Atrial Fibrillation Detected on Apple Watch Heart Rhythm Device

FDA has cleared the KardiaBand device to recordtheir EKG to detect normal heart rhythms and atrial fibrillation.

Antithrombotic Therapy for Atrial Fibrillation and Valvular Heart Disease: New Joint Consensus Statement

Antithrombotic Therapy for Atrial Fibrillation and Valvular Heart Disease: New Joint Consensus Statement

A new consensus statement provides updated guidelines for antithrombotic therapy in patients with atrial fibrillation associated with valvular heart disease.

ACC Expert Consensus: Management of Bleeding Associated With Oral Anticoagulants

ACC Expert Consensus: Management of Bleeding Associated With Oral Anticoagulants

The American College of Cardiology released an expert consensus decision pathway intended to guide clinicians in managing bleeding in patients treated with anticoagulation.

Incident Atrial Fibrillation: Direct Oral Anticoagulants vs Warfarin

Incident Atrial Fibrillation: Direct Oral Anticoagulants vs Warfarin

Compared with warfarin, direct oral anticoagulants lowered the risk for stroke and death risk in patients with incident atrial fibrillation.

Atrial Fibrillation Subtypes: Comparing Mortality Risks

Atrial Fibrillation Subtypes: Comparing Mortality Risks

Persistent atrial fibrillation is associated with a higher risk for mortality compared with paroxysmal atrial fibrillation.

Subclinical Atrial Fibrillation Detection: Holter vs Insertable Cardiac Monitor

Subclinical Atrial Fibrillation Detection: Holter vs Insertable Cardiac Monitor

Continuous monitoring with an insertable cardiac monitor was found to be superior at detecting subclinical atrial fibrillation compared with a Holter monitor.

FDA Approves Rivaroxaban 10 mg for Recurrent VTE

FDA Approves Rivaroxaban 10 mg for Recurrent VTE

The 10 mg dose of rivaroxaban substantially lowered the risk for recurrent venous thromboembolism.

LAA Closure vs Warfarin for Stroke Prevention in Atrial Fibrillation

LAA Closure vs Warfarin for Stroke Prevention in Atrial Fibrillation

A left atrial appendage closure device provided a similar level of stroke prevention to that of warfarin in patients with atrial fibrillation.

Additional Ablation for Atrial Fibrillation Not Warranted After Change in Inducibility

Additional Ablation for Atrial Fibrillation Not Warranted After Change in Inducibility

Change in inducibility status after pulmonary vein isolation is not associated with long-term freedom from recurrent arrhythmia.

Atrial Fibrillation Survival Better With Cardiac Surgery, Cox-Maze IV

Atrial Fibrillation Survival Better With Cardiac Surgery, Cox-Maze IV

Patients with atrial fibrillation had improved late survival when treated with ablation-assisted Cox-Maze IV and cardiac surgery.

Bleeding Events in Atrial Fibrillation: Assessing Risk Prediction Models

Bleeding Events in Atrial Fibrillation: Assessing Risk Prediction Models

Risk prediction models to assess bleeding risk in patients with atrial fibrillation may be useful for optimizing treatment.

Post-Stroke Atrial Fibrillation Increases Risk for Cognitive Deficits

Post-Stroke Atrial Fibrillation Increases Risk for Cognitive Deficits

Risk for poststroke cognitive impairment is increased by the presence of atrial fibrillation.

Predominant Sleep Disorders in Atrial Fibrillation Classified by Apneas and Hypopneas

Predominant Sleep Disorders in Atrial Fibrillation Classified by Apneas and Hypopneas

Classification of predominant obstructive sleep apnea in atrial fibrillation is affected by use of apneas vs hypopneas.

Lower Afib Risk With AdaptivCRT vs Conventional Cardiac Resynchronization Therapy

Lower Afib Risk With AdaptivCRT vs Conventional Cardiac Resynchronization Therapy

Patients who received synchronized left ventricular pacing with the AdaptivCRT had a lower risk of developing atrial fibrillation compared with patients who received conventional cardiac resynchronization therapy.

Atrial Fibrillation in Geriatric Patients Identified Using Daily Rhythm Recordings

Atrial Fibrillation in Geriatric Patients Identified Using Daily Rhythm Recordings

Daily short-term rhythm recordings may help diagnose atrial fibrillation in geriatric patients.

Prognostic Significance of Gender in Atrial Fibrillation and Diabetes

Prognostic Significance of Gender in Atrial Fibrillation and Diabetes

Women with atrial fibrillation and diabetes have higher rates for mortality and cardiovascular disease compared to men.

New Atrial Fibrillation After Stroke Tied to Preexisting Cardiovascular Comorbidities

New Atrial Fibrillation After Stroke Tied to Preexisting Cardiovascular Comorbidities

Patients diagnosed with new atrial fibrillation after ischemic stroke were more likely to have preexisting cardiovascular comorbidities such as hypertension, heart failure, and coronary artery disease.

Long-Term Aspirin Unnecessary Following Atrial Fibrillation Ablation

Long-Term Aspirin Unnecessary Following Atrial Fibrillation Ablation

Patients with atrial fibrillation who are at a low risk for stroke do not receive a major benefit from long-term aspirin therapy.

Heart Failure, Arrhythmia Risk Increased With Zoledronic Acid

Heart Failure, Arrhythmia Risk Increased With Zoledronic Acid

Patients treated with zoledronic acid had a higher risk for atrial fibrillation and other arrhythmias as well as heart failure vs untreated patients.

Atrial Fibrillation Risk Increased With Type 1 Diabetes, Poor Renal Function

Atrial Fibrillation Risk Increased With Type 1 Diabetes, Poor Renal Function

Patients with type 1 diabetes have an increased risk for atrial fibrillation.

Intraocular Bleeding Risk Reduced With NOACS Compared With Warfarin

Intraocular Bleeding Risk Reduced With NOACS Compared With Warfarin

Novel oral anticoagulants lead to a one-fifth reduction in the risk of intraocular bleeding, compared with warfarin in patients with atrial fibrillation or venous thromboembolism.

Newly Diagnosed Atrial Fibrillation Benefits From Cardiology Care vs Primary Care

Newly Diagnosed Atrial Fibrillation Benefits From Cardiology Care vs Primary Care

Cardiology care in patients with newly diagnosed atrial fibrillation was associated with reductions in stroke and death.

Elevated High-Sensitivity Troponin T in Afib May Not Increase Coronary Event Risk

Elevated High-Sensitivity Troponin T in Afib May Not Increase Coronary Event Risk

Patients with atrial fibrillation but without known coronary artery disease may not be at an increased risk for coronary events, despite elevated high-sensitivity troponin T levels.

Poll: Surgical Ablation for Atrial Fibrillation

Poll: Surgical Ablation for Atrial Fibrillation

The American Association for Thoracic Surgery recently released guidelines on the use of surgical ablation in atrial fibrillation.

American Association for Thoracic Surgery Guidelines on Surgical Ablation for Atrial Fibrillation

American Association for Thoracic Surgery Guidelines on Surgical Ablation for Atrial Fibrillation

The American Association for Thoracic Surgery has developed evidence-based guidelines on the use of surgical ablation for atrial fibrillation.

Effect of Obesity Paradox on Venous Thromboembolism Risk in Atrial Fib

Effect of Obesity Paradox on Venous Thromboembolism Risk in Atrial Fib

A meta-analysis was conducted to examine concerns surrounding direct oral anticoagulant therapy in patients with extreme high or low body weight.

Lone Atrial Fibrillation Clinical Characteristics in Children

Lone Atrial Fibrillation Clinical Characteristics in Children

Children aged 15-19 years appear to have the greatest risk of developing lone atrial fibrillation.

Left Atrial Appendage Isolation for Stable Sinus Rhythm

Left Atrial Appendage Isolation for Stable Sinus Rhythm

Although stable sinus rhythm was achieved in some patients after LAA isolation, embolic stroke and LAA thrombus formation was still problematic.

Dementia Risk in Atrial Fibrillation Increases With Delayed Anticoagulation

Dementia Risk in Atrial Fibrillation Increases With Delayed Anticoagulation

The delayed start of anticoagulation treatment for atrial fibrillation has been linked to an increase risk for dementia.

Newly Diagnosed Atrial Fibrillation Benefits From Rivaroxaban, Dabigatran

Newly Diagnosed Atrial Fibrillation Benefits From Rivaroxaban, Dabigatran

Direct oral anticoagulation reduced the risk of congestive heart failure admissions and all-cause mortality in both genders.

Sudden Cardiac Death/Ventricular Arrhythmia Risk in Atrial Fibrillation

Sudden Cardiac Death/Ventricular Arrhythmia Risk in Atrial Fibrillation

The annual risk of sudden cardiac death/ventricular arrhythmias was higher in patients with atrial fibrillation vs patients without atrial fibrillation.

Atrial Fibrillation Risk Reduced With Diabetes Medications

Atrial Fibrillation Risk Reduced With Diabetes Medications

Thiazolidinediones reduced the risk of atrial fibrillation by 30% in an analysis of pooled data from 7 studies.

Renin-Angiotensin System Inhibition Effect on Post-MI Mortality and New-Onset Atrial Fibrillation

Renin-Angiotensin System Inhibition Effect on Post-MI Mortality and New-Onset Atrial Fibrillation

Renin-angiotensin system inhibition was linked with a reduced 3-year risk of all-cause mortality in patients with congestive heart failure and atrial fibrillation.

Obesity Paradox Reported for CVD Death Outcomes in Atrial Fibrillation

Obesity Paradox Reported for CVD Death Outcomes in Atrial Fibrillation

A systematic review of BMI and major adverse events in AF concluded that further evidence is necessary to clarify the relationship between obesity and AF.

Can Apixaban Reduce Intracranial Hemorrhage Risk vs Warfarin in Afib?

Can Apixaban Reduce Intracranial Hemorrhage Risk vs Warfarin in Afib?

Patients with atrial fibrillation taking apixaban showed significantly less intracranial hemorrhage compared with patients taking warfarin.

Prevalence of Inadequate Therapeutic Anticoagulation for Afib Preceding Ischemic Stroke Examined

Prevalence of Inadequate Therapeutic Anticoagulation for Afib Preceding Ischemic Stroke Examined

Inadequate therapeutic anticoagulation prior to the occurrence of ischemic stroke was found to be prevalent.

Uninterrupted Anticoagulation With Dabigatran Improves Atrial Fibrillation Ablation Outcomes, Expert Q&A

Uninterrupted Anticoagulation With Dabigatran Improves Atrial Fibrillation Ablation Outcomes, Expert Q&A

Incidence of major bleeding events was lower with dabigatran vs warfarin in atrial fibrillation ablation.

Atrial Fibrillation Associated With Higher Mortality in STEMI

Atrial Fibrillation Associated With Higher Mortality in STEMI

Atrial fibrillation was associated with a higher risk of adjusted in-hospital mortality and bleeding complications after both PCI and CABG.

Higher CHADS2 Score in Atrial Fibrillation Linked to Increased Dementia Risk

Higher CHADS2 Score in Atrial Fibrillation Linked to Increased Dementia Risk

CHADS2 scores in patients with atrial fibrillation are associated with increased risk of developing dementia.

Prestroke CHA2DS2-VASc Predictive of Stroke Severity, Mortality

Prestroke CHA2DS2-VASc Predictive of Stroke Severity, Mortality

The relationship between prestroke CHA2DS2-VASc score and stroke severity and functional outcome in patients with AF and acute ischemic stroke was evaluated.

Atrial Fibrillation Recurrence Not Reduced With Aggressive Blood Pressure Control

Atrial Fibrillation Recurrence Not Reduced With Aggressive Blood Pressure Control

Aggressive blood pressure treatment did not reduce atrial fibrillation recurrence after catheter ablation.

Dabigatran Bleeding Risk Stratified by Age in Atrial Fibrillation

Dabigatran Bleeding Risk Stratified by Age in Atrial Fibrillation

Compared with warfarin, there were lower rates of stroke with dabigatran 110 mg and 150 mg twice daily.

Oral Anticoagulant Stroke Risk in Atrial Fibrllation

Oral Anticoagulant Stroke Risk in Atrial Fibrllation

Patients taking apixaban were more likely to experience ischemic stroke or systemic embolism vs patients taking warfarin.

Heart Failure, Atrial Fibrillation: Possible Markers for Mild Alzheimer's

Heart Failure, Atrial Fibrillation: Possible Markers for Mild Alzheimer's

Patients with both heart failure and atrial fibrillation had a pattern of milder Alzheimer's pathology.

LDL Cholesterol Predicts Ischemic Stroke in Atrial Fibrillation

LDL Cholesterol Predicts Ischemic Stroke in Atrial Fibrillation

Low-density lipoprotein cholesterol independently predicts ischemic stroke in patients with atrial fibrillation.

Periprocedural Anticoagulation in Atrial Fibrillation: American College of Cardiology Decision Pathway

Periprocedural Anticoagulation in Atrial Fibrillation: American College of Cardiology Decision Pathway

The American College of Cardiology released a decision pathway for managing periprocedural anticoagulation in patients with nonvalvular atrial fibrillation

Can Stroke Predict Atrial Fibrillation?

Can Stroke Predict Atrial Fibrillation?

The researchers assessed 1809 patients with incidence of stroke and atrial fibrillation.

Insulin, Not Diabetes, May Increase Thromboembolic Risk in Atrial Fibrillation

Insulin, Not Diabetes, May Increase Thromboembolic Risk in Atrial Fibrillation

Insulin-requiring diabetes was associated with a higher risk for stroke/systemic embolism incidence at 1-year follow-up.

LAA Closure Device in Atrial Fibrillation Yields High Success, Low Complication Rates

LAA Closure Device in Atrial Fibrillation Yields High Success, Low Complication Rates

The left atrial appendage closure device was found to have excellent success and low complication rates in a post-FDA approval study.

Silent Cerebrovascular Disease Increases Risk for Future Stroke

Silent Cerebrovascular Disease Increases Risk for Future Stroke

Silent cerebrovascular disease appears to increase the risk for future symptomatic stroke.

Atrial Fibrillation Clinical Guidelines: A Review of the Evidence Base

Atrial Fibrillation Clinical Guidelines: A Review of the Evidence Base

While the number of recommendations has increased, level A evidence is assigned to only 8.8% of the atrial fibrillation clinical guidelines.

Off-Label Dosing of NOACs in Atrial Fibrillation Is a Concern

Off-Label Dosing of NOACs in Atrial Fibrillation Is a Concern

About 1 in 8 patients in the ORBIT-AF II registry were given "off-label" non-vitamin K antagonist doses.

Main Cause of Mortality in Anticoagulated Atrial Fibrillation

Main Cause of Mortality in Anticoagulated Atrial Fibrillation

Cardiac-related death is the main cause of mortality among patients with atrial fibrillation on anticoagulants.

Trans-esophageal Echocardiography Trends in Atrial Fibrillation Ablation

Trans-esophageal Echocardiography Trends in Atrial Fibrillation Ablation

Pre-ablation trans-esophageal echocardiography rates dropped from 86% to 42%; meanwhile, cerebrovascular accidents occurred in only 0.40% of patients.

Atrial Fibrillation Risk May Be Affected by Sleep Duration

Atrial Fibrillation Risk May Be Affected by Sleep Duration

Reduced REM sleep was correlated with a 23% increased risk of atrial fibrillation.

Revisiting Necessity of Full Dose Triple Therapy With DAPT for Routine PCI

Revisiting Necessity of Full Dose Triple Therapy With DAPT for Routine PCI

All-cause death plus hospitalization possibly from bleeding were reduced in both rivaroxaban groups compared with the reference group.

Watchman Device Linked to Low Complications, Successful Procedures

Watchman Device Linked to Low Complications, Successful Procedures

Procedural data from the WATCHMAN clinical trial presented at TCT demonstrated the device implantation success rate in patients with nonvalvular atrial fibrillation.

Should Anticoagulation Be Given in Afib/Atrial Tachycardia With ICDs?

Should Anticoagulation Be Given in Afib/Atrial Tachycardia With ICDs?

Anticoagulation therapy may not reduce stroke risk for patients with ICDs who have only brief episodes of AT or AF.

Is There Clinical Benefit to >3 Month Rivaroxaban Tx for Unprovoked VTE?

Is There Clinical Benefit to >3 Month Rivaroxaban Tx for Unprovoked VTE?

Two studies presented at CHEST 2016 revealed that rivaroxaban lowered the risk of venous thromboembolism without increasing risk of major bleeding.

LAA Isolation Increases Arrhythmia-Free Interval Post-Catheter Ablation

LAA Isolation Increases Arrhythmia-Free Interval Post-Catheter Ablation

At 12 months, 56% of patients who received empirical electrical LAA isolation were recurrence-free, compared with 28% of patients who received standard ablation alone.

Sex-Specific Differences in New-Onset Afib Post-CABG

Sex-Specific Differences in New-Onset Afib Post-CABG

Patients with new-onset atrial fibrillation after CABG experience higher rates of morbidity and poor long-term survival outcomes compared to women.

High-Sensitivity Cardiac Troponin T Levels Linked to Cerebral Microbleeds

High-Sensitivity Cardiac Troponin T Levels Linked to Cerebral Microbleeds

Patients in the highest hs-cTnT tertile were more likely to have cerebral microbleeds and deep or infratentorial cerebral microbleeds, after adjustments.

Low-Dose NOACs Reduce Thromboembolic Events in Nonvalvular AF

Low-Dose NOACs Reduce Thromboembolic Events in Nonvalvular AF

Compared with patients taking warfarin, patients treated with rivaroxaban and dabigatran had significantly lower rates of intracranial hemorrhage, ischemic stroke or systemic, and all-cause mortality.

Atrial Fibrillation Risk Increased With Alcohol Consumption

Atrial Fibrillation Risk Increased With Alcohol Consumption

Cumulative alcohol consumption is associated with left atrial enlargement, which increases atrial fibrillation risk.

Atrial Fibrillation Ablation: Reducing Cardiac Tamponade

Atrial Fibrillation Ablation: Reducing Cardiac Tamponade

Patients treated with balloon ablation for atrial fibrillation had the lowest rates of cardiac tamponade.

Oral Anticoagulation in Atrial Fibrillation: Does Comorbid Heart Failure Matter?

Oral Anticoagulation in Atrial Fibrillation: Does Comorbid Heart Failure Matter?

Stroke/systemic embolism rates were comparable between patients with atrial fibrillation with or without heart failure.

CV Risk Factors May Precede Atrial Fibrillation Diagnosis By Several Years

CV Risk Factors May Precede Atrial Fibrillation Diagnosis By Several Years

Investigators identified a J-shape pattern to the prevalence of heart failure, MI, and stroke, with sharp increases just before diagnosis of atrial fibrillation.

Atrial Fibrillation Associated With Increased Complications After PCI

Atrial Fibrillation Associated With Increased Complications After PCI

Patients with a history of atrial fibrillation were more likely to have postprocedural bleeding, blood transfusion, heart failure, cardiogenic shock, and in-hospital mortality.

Antiplatelet Therapy With Vitamin K Antagonists Does Not Reduce Stroke in Afib After TAVR

Antiplatelet Therapy With Vitamin K Antagonists Does Not Reduce Stroke in Afib After TAVR

No differences between monotherapy and multiple anthrombotic therapy in rates of stroke, MACE, or death.

Sign Up for Free e-Newsletters